Skip to main content
. Author manuscript; available in PMC: 2012 May 7.
Published in final edited form as: Mol Pharm. 2009 Jan-Feb;6(1):29–39. doi: 10.1021/mp800148u

Table 6.

pKa values, maximum dose, and salt forms of some BCS II weak acids.

Compound pKa values Maximum dose (mg) Acid/salt form Provisional BCS classification
Acetyl-salicylic acid 3.5 (47) 975 Free acid BCS I or III
Atorvastatin 4.46 (47) 80 Calcium salt BCS II (48)
Diacerein 4.74* 50 Free acid non-us marketed drug
Diclofenac 4.2 (49) 50 K and Na salts BCS II
Diflunisal 3.0 (47) 500 Free acid BCS II
Etodolac 4.7 (47) 400 Free acid BCS II
Epalrestat 3.2* 50 Free acid non-us drug
Fenoprofen 4.5 (49) 600 Calcium salt BCS II
Flurbiprofen 4.3 (49) 100 Free acid BCS II
Fluvastatin 4.76* 40 Na salt BCS II
Furosemide 3.88, 9.37* 80 Free acid BCS II
Ibuprofen 4.4 (49) 800 Free acid BCS II
Indomethacin 4.5 (49) 50 Free acid BCS II
Ketoprofen 4.76 (49) 75 Free acid BCS II
Ketorolac 3.5 (49) 20 Tromethamine salt Salt form: BCS I
Mefenamic acid 4.2 (47) 250 Free acid BCS II
Meloxicam 1.1, 4.2 (50) 15 Free acid BCS II
Naproxen 500 Free acid Acid: BCS II (51)
4.2 (49) 500 Na salt Na salt: BCS I (52)
Oxaprozin 4.3 (50) 600 Free acid BCS II
Piroxicam 1.8, 5.1 (50) 20 Free acid BCS II
Salicylic acid 3.0 (47) 750 Free acid BCS I
Sulindac 4.5 (49) 200 Free acid BCS II
Triflusal 4.15* 300 Free acid non-us drug
Tolmetin (53) 3.5 (49) 600 Na salt BCS II
Zaltoprofen 4.44* 80 Free acid non-us drug
Warfarin 5.35* 10 Na salt (54) BCS I
*

calculated using Program ADMET version 1.2.3,